Failure to detect in vivo inverse agonism of the 5-HT1B receptor antagonist SB-224289 in 5-HT-depleted guinea-pigs

[1]  J. Javitch,et al.  Mechanisms of inverse agonism of antipsychotic drugs at the D2 dopamine receptor: use of a mutant D2 dopamine receptor that adopts the activated conformation , 2001, Journal of neurochemistry.

[2]  S. Ross,et al.  Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  Hong Yu,et al.  Enhanced 5-HT metabolism and synthesis rate by the new selective r5-HT1B receptor antagonist, NAS-181 in the rat brain , 2000, Neuropharmacology.

[4]  D. Middlemiss,et al.  Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade , 1999, Neuropharmacology.

[5]  A. Gobert,et al.  Inverse Agonists and Serotonergic Transmission: From Recombinant, Human Serotonin (5-HT)1B Receptors to G-Protein Coupling and Function in Corticolimbic Structures in vivo , 1999, Neuropsychopharmacology.

[6]  L. Larsson,et al.  Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[7]  D. Middlemiss,et al.  SB‐224289–a novel selective (human) 5‐HT1B receptor antagonist with negative intrinsic activity , 1998, British journal of pharmacology.

[8]  D. Middlemiss,et al.  Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions. , 1998, European journal of pharmacology.

[9]  P. Pauwels,et al.  Pharmacological analysis of G‐protein activation mediated by guinea‐pig recombinant 5‐HT1B receptors in C6‐glial cells: similarities with the human 5‐HT1B receptor , 1998, British journal of pharmacology.

[10]  G. Milligan,et al.  Inverse agonism and the regulation of receptor number. , 1997, Trends in pharmacological sciences.

[11]  J. Hagan,et al.  Stimulation of 5-HT1B receptors causes hypothermia in the guinea pig. , 1997, European journal of pharmacology.

[12]  H. Rollema,et al.  Combined Administration of a 5‐Hydroxytryptamine (5‐HT)1D Antagonist and a 5‐HT Reuptake Inhibitor Synergistically Increases 5‐HT Release in Guinea Pig Hypothalamus In Vivo , 1996, Journal of neurochemistry.

[13]  S. Hjorth,et al.  Studies on the role of 5-HT1A autoreceptors and α 1-adrenoceptors in the inhibition of 5-HT release—I. BMY7378 and prazosin , 1995, Neuropharmacology.

[14]  M. Diksic,et al.  The Acute Effects of Reserpine and NSD-1015 on the Brain Serotonin Synthesis Rate Measured by an Autoradiographic Method , 1995, Neuropsychopharmacology.

[15]  D. Pearce,et al.  The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HTT concentration and behaviour in the guinea pig , 1995, Neuropharmacology.

[16]  A. Sleight,et al.  Effects of the 5-HT1D receptor antagonist GR127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis , 1995, Neuropharmacology.

[17]  M. Foguet,et al.  Long‐term regulation of serotonergic activity in the rat brain via activation of protein kinase A. , 1993, The EMBO journal.

[18]  R. Tao,et al.  The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. , 1991, European journal of pharmacology.

[19]  P. Pévet,et al.  Tryptophan Hydroxylase Synthesis Is Induced by 3′, 5′‐Cyclic Adenosine Monophosphate During Circadian Rhythm in the Rat Pineal Gland , 1991, Journal of neurochemistry.

[20]  M. Millan,et al.  Inability of an opioid antagonist lacking negative intrinsic activity to induce opioid receptor up‐regulation in vivo , 1991, British journal of pharmacology.

[21]  M. Goldstein,et al.  Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. , 1990, Molecular pharmacology.

[22]  S. Ross,et al.  Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT , 1990, Neuropharmacology.

[23]  D G Grahame-Smith,et al.  5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis , 1989, British journal of pharmacology.

[24]  G. Aghajanian,et al.  (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. , 1986, European journal of pharmacology.

[25]  D. Westerlund,et al.  Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography--electrochemical detection system. , 1980, Journal of chromatography.

[26]  E. Schlicker,et al.  Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[27]  E. Schlicker,et al.  Regulation of 5-HT Release in the CNS by Presynaptic 5-HT Autoreceptors and by 5-HT Heteroreceptors , 2000 .

[28]  C. de Montigny,et al.  Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain , 1987, Synapse.